Journal article icon

Journal article

Kynurenine pathway metabolites in Alzheimer's disease.

Abstract:

Background

Metabolites of tryptophan, produced via the kynurenine pathway (kynurenines) have been linked to Alzheimer’s disease (AD) in small cohorts with conflicting results.

Objective

To compare differences in plasma kynurenine levels between AD and controls and identify potential associations with cognition.

Methods

The study included 65 histopathologically-confirmed AD patients and 65 cognitively-screened controls from the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Cognition was assessed using the Cambridge Cognitive Examination (CamCog). Tryptophan, kynurenines, neopterin and vitamin B6 forms were measured in plasma by liquid chromatography-tandem mass spectrometry. Non-parametric statistics, logistic regression and standardized robust regressions were applied with a false discovery rate of 0.05.

Results

Tryptophan, xanthurenic acid, 3-hydroxyanthranilic acid and quinolinic acid were lower in AD (Odds ratios (ORs) 0.24 – 0.47; p-values < 0.001 – 0.01). Pyridoxal 5’phosphate did not differ between AD and controls. Kynurenine, anthranilic acid, quinolinic acid and markers of immune activation (neopterin, kynurenine/tryptophan ratio and the PAr index (Pyridoxic acid/(Pyridoxal 5’phosphate + Pyridoxal)) increased with age (β 0.31 – 0.51; p-values < 0.001 – 0.006). Xanthurenic acid decreased with age (β: -0.42, p < 0.001). Elderly AD patients with high quinolinic acid performed worse on the CamCog test, indicated by a significant age*quinolinic acid interaction (β 0.21, p < 0.001).

Conclusion

Plasma concentrations of several kynurenines were lower in patients with AD compared to controls. Low xanthurenic acid occurred in both AD and with ageing. Inflammation-related markers were associated with age, but not AD. However, elevated QA was associated with poor cognition in older AD patients.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.3233/jad-170485

Authors

More by this author
Role:
Author
ORCID:
0000-0003-3520-7530
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Pharmacology
Role:
Author


Publisher:
IOS Press
Journal:
Journal of Alzheimer's Disease More from this journal
Volume:
60
Issue:
2
Pages:
495-504
Publication date:
2017-09-01
Acceptance date:
2017-07-07
DOI:
EISSN:
1875-8908
ISSN:
1387-2877
Pmid:
28869479


Language:
English
Keywords:
Pubs id:
pubs:725881
UUID:
uuid:d4714fac-9c39-484a-baf9-82dd68dc1984
Local pid:
pubs:725881
Source identifiers:
725881
Deposit date:
2018-02-20
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP